Cryomass Technologies Inc Malpractice Loss Contingency, Claims Incurred, Net
Cryomass Technologies Inc reported Malpractice Loss Contingency, Claims Incurred, Net of $7.96 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MalpracticeLossContingencyClaimsIncurredNet · last filed 2023-08-21
- Cryomass Technologies Inc malpractice loss contingency, claims incurred, net for the quarter ending 2023-06-30 was $6.36M, a 344.75% increase year-over-year.
- Cryomass Technologies Inc malpractice loss contingency, claims incurred, net for the quarter ending 2023-03-31 was $1.60M, a 25.73% decline year-over-year.
- Cryomass Technologies Inc malpractice loss contingency, claims incurred, net for the quarter ending 2022-12-31 was $5.61M.
- Cryomass Technologies Inc malpractice loss contingency, claims incurred, net for the quarter ending 2022-09-30 was $1.23M.
- Cryomass Technologies Inc malpractice loss contingency, claims incurred, net for fiscal 2022 was $10.42M, a 18.95% decline from fiscal 2021.
- Cryomass Technologies Inc malpractice loss contingency, claims incurred, net for fiscal 2021 was $12.86M.
| Period end | Malpractice Loss Contingency, Claims Incurred, Net 3 month | Malpractice Loss Contingency, Claims Incurred, Net 6 month | Malpractice Loss Contingency, Claims Incurred, Net 9 month | Malpractice Loss Contingency, Claims Incurred, Net 12 month |
|---|---|---|---|---|
| 2023-06-30 | $6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $7.96M 10-Q · filed 2023-08-21 | $13.57M derived: sum of 3 quarters · filed 2023-08-21 | $14.80M derived: sum of 4 quarters · filed 2023-08-21 |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-15 | $7.21M derived: sum of 2 quarters · filed 2023-05-15 | $8.44M derived: sum of 3 quarters · filed 2023-05-15 | $9.87M derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $6.84M derived: sum of 2 quarters · filed 2023-03-24 | $8.27M derived: sum of 3 quarters · filed 2023-03-24 | $10.42M 10-K · filed 2023-03-24 |
| 2022-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.66M derived: sum of 2 quarters · filed 2022-11-10 | $4.81M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.58M 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $2.15M 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $12.86M 10-K · filed 2022-03-28 |